Clinical Trials Browser

Phase 1 × Aprepitant × 1 year × Clear all

NCT06931119 2025-04-17

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Phase 1 Not yet recruiting

Pruritus